Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
The original GLP-1 receptor agonist was exenatide, which itself was a synthetic version of exendin-4
:max_bytes(150000):strip_icc()/VWH-AmeliaManley-DrugsforWeightloss-Standard-a7ded96a29944c87b7b96ae6deb22f03.jpg)
Another trial published in The Lancet in 2017 demonstrated that exenatide (Byetta) improved motor function in patients with Parkinson's disease, with some exploratory cognitive measures showing potential benefit, though the study was limited by small sample size and short duration
Internal Wisdom At its core, GLP-1 (Glucagon-like peptide-1) is a hormone our bodies naturally produce in the gut
392, Mar
Author contributions LZ: Formal Analysis, Writing original draft, Methodology, Conceptualization
,aspect=ignore)
US$ 24.52
US$ 25.39
US$ 25.43
,aspect=ignore)
US$ 26.59
